Stifel Financial Corp lifted its holdings in shares of Cognex Co. (NASDAQ:CGNX) by 55.3% during the 2nd quarter, Holdings Channel.com reports. The firm owned 67,877 shares of the scientific and technical instruments company’s stock after purchasing an additional 24,178 shares during the period. Stifel Financial Corp’s holdings in Cognex were worth $4,053,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the company. Fieldpoint Private Securities LLC grew its holdings in shares of Cognex by 3.9% during the first quarter. Fieldpoint Private Securities LLC now owns 5,633 shares of the scientific and technical instruments company’s stock worth $237,000 after purchasing an additional 211 shares during the last quarter. Cigna Investments Inc. New boosted its holdings in Cognex by 6.7% in the first quarter. Cigna Investments Inc. New now owns 4,769 shares of the scientific and technical instruments company’s stock valued at $201,000 after acquiring an additional 300 shares during the last quarter. Creative Financial Designs Inc. ADV bought a new position in Cognex in the second quarter valued at about $26,000. Banque Cantonale Vaudoise boosted its holdings in Cognex by 5.3% in the first quarter. Banque Cantonale Vaudoise now owns 9,014 shares of the scientific and technical instruments company’s stock valued at $380,000 after acquiring an additional 455 shares during the last quarter. Finally, Loomis Sayles & Co. L P boosted its holdings in Cognex by 14.8% in the first quarter. Loomis Sayles & Co. L P now owns 4,664 shares of the scientific and technical instruments company’s stock valued at $197,000 after acquiring an additional 602 shares during the last quarter. Institutional investors own 93.62% of the company’s stock.

CGNX stock opened at $64.25 on Wednesday. The business has a 50 day moving average price of $66.16 and a two-hundred day moving average price of $56.43. The company has a market cap of $11.03 billion, a price-to-earnings ratio of 79.32 and a beta of 1.67. Cognex Co. has a twelve month low of $35.20 and a twelve month high of $71.76.

Cognex (NASDAQ:CGNX) last issued its earnings results on Wednesday, July 29th. The scientific and technical instruments company reported ($0.01) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.10 by ($0.11). Cognex had a return on equity of 10.67% and a net margin of 20.50%. The business had revenue of $169.10 million for the quarter, compared to the consensus estimate of $149.90 million. During the same quarter in the prior year, the firm posted $0.27 earnings per share. The business’s revenue was down 15.0% compared to the same quarter last year. On average, equities analysts forecast that Cognex Co. will post 0.75 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, August 28th. Stockholders of record on Friday, August 14th were paid a dividend of $0.055 per share. The ex-dividend date was Thursday, August 13th. This represents a $0.22 annualized dividend and a dividend yield of 0.34%. Cognex’s dividend payout ratio is currently 18.97%.

In other news, CEO Robert Willett sold 100,000 shares of the business’s stock in a transaction on Friday, July 31st. The stock was sold at an average price of $65.93, for a total transaction of $6,593,000.00. Following the completion of the transaction, the chief executive officer now owns 100,000 shares of the company’s stock, valued at approximately $6,593,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Jerry A. Schneider sold 5,000 shares of the business’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $66.73, for a total value of $333,650.00. Following the transaction, the director now directly owns 5,000 shares of the company’s stock, valued at approximately $333,650. The disclosure for this sale can be found here. Insiders have sold a total of 479,522 shares of company stock valued at $32,446,379 over the last quarter. 5.20% of the stock is currently owned by corporate insiders.

Several equities analysts recently issued reports on the company. reiterated a “sell” rating on shares of Cognex in a report on Tuesday, June 9th. Morgan Stanley raised their target price on Cognex from $39.00 to $55.00 and gave the stock an “underweight” rating in a report on Friday, July 31st. Zacks Investment Research lowered Cognex from a “hold” rating to a “sell” rating in a research report on Wednesday, July 1st. HSBC assumed coverage on Cognex in a research report on Monday, May 25th. They set a “hold” rating and a $55.00 price target on the stock. Finally, Daiwa Capital Markets lowered Cognex from an “outperform” rating to a “neutral” rating in a research report on Friday, September 4th. Six investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $52.82.

Cognex Company Profile

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. It provides machine vision products, which are used to automate the manufacture and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Featured Article: Blue-Chip Stocks

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Co. (NASDAQ:CGNX).

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.